{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:54Z","timestamp":1792454454931,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008335","name":"Arizona Biomedical Research Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008335","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.ejps.2019.105124","type":"journal-article","created":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T12:16:05Z","timestamp":1572956165000},"page":"105124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Discovery of M2 channel blockers targeting the drug-resistant double mutants M2-S31N\/L26I and M2-S31N\/V27A from the influenza A viruses"],"prefix":"10.1016","volume":"141","author":[{"given":"Rami","family":"Musharrafieh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4845-4621","authenticated-orcid":false,"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2019.105124_bib0001","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1128\/AAC.49.2.556-559.2005","article-title":"Generation and characterization of recombinant influenza A (H1N1) viruses harboring amantadine resistance mutations","volume":"49","author":"Abed","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2019.105124_bib0002","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.diagmicrobio.2009.12.019","article-title":"Double (V27A\/S31N) mutant 2009 pandemic influenza A (H1N1) virus isolated from adamantane non-treated inmunocompetent child","volume":"67","author":"Anton","year":"2010","journal-title":"Diagnostic Microbio. Infect. Dis."},{"key":"10.1016\/j.ejps.2019.105124_bib0003","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1021\/ja102581n","article-title":"Specific binding of adamantane drugs and direction of their polar amines in the pore of the influenza M2 transmembrane domain in lipid bilayers and dodecylphosphocholine micelles determined by NMR spectroscopy","volume":"133","author":"Cady","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejps.2019.105124_bib0004","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1086\/504723","article-title":"Distribution of amantadine-resistant H5N1 avian influenza variants in Asia","volume":"193","author":"Cheung","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ejps.2019.105124_bib0005","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/nm1477","article-title":"Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia","volume":"12","author":"de Jong","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejps.2019.105124_bib0006","first-page":"20","article-title":"Adamantane-Resistant influenza A viruses in the world (1902\u20132013): frequency and distribution of M2 gene mutations","volume":"10","author":"Dong","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejps.2019.105124_bib0007","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nature04017","article-title":"Strategies for containing an emerging influenza pandemic in Southeast Asia","volume":"437","author":"Ferguson","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2019.105124_bib0008","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.antiviral.2013.02.013","article-title":"Antiviral resistance among highly pathogenic influenza A (H5N1) viruses isolated worldwide in 2002\u20132012 shows need for continued monitoring","volume":"98","author":"Govorkova","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.ejps.2019.105124_bib0009","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1126\/science.1062882","article-title":"Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses","volume":"293","author":"Hatta","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.ejps.2019.105124_bib0010","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1126\/science.1213362","article-title":"Airborne transmission of influenza A\/H5N1 virus between ferrets","volume":"336","author":"Herfst","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.ejps.2019.105124_bib0011","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1126\/science.1191714","article-title":"Mechanisms of proton conduction and gating in influenza M2 proton channels from solid-state NMR","volume":"330","author":"Hu","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.ejps.2019.105124_bib0012","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1021\/acsmedchemlett.8b00336","article-title":"Structure\u2013property relationship studies of influenza A virus AM2-S31N proton channel blockers","volume":"9","author":"Hu","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2019.105124_bib0013","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.2174\/1568026617666170224122508","article-title":"Influenza A virus nucleoprotein: a highly conserved multi-functional viral protein as a hot antiviral drug target","volume":"17","author":"Hu","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejps.2019.105124_bib0014","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejmech.2017.04.038","article-title":"Design and expeditious synthesis of organosilanes as potent antivirals targeting multidrug-resistant influenza A viruses","volume":"135","author":"Hu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2019.105124_bib0015","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.antiviral.2017.01.006","article-title":"An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and-resistant influenza A viruses","volume":"140","author":"Hu","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ejps.2019.105124_bib0016","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.coviro.2014.04.009","article-title":"The epidemiology and spread of drug resistant human influenza viruses","volume":"8","author":"Hurt","year":"2014","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.ejps.2019.105124_bib0017","doi-asserted-by":"crossref","first-page":"10967","DOI":"10.1073\/pnas.0804958105","article-title":"Functional studies indicate amantadine binds to the pore of the influenza A virus M2 proton-selective ion channel","volume":"105","author":"Jing","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejps.2019.105124_bib0018","article-title":"Identification of the I38T PA substitution as a resistance marker for next-generation influenza virus endonuclease inhibitors","volume":"9","author":"Jones","year":"2018","journal-title":"MBio"},{"key":"10.1016\/j.ejps.2019.105124_bib0019","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1016\/S1473-3099(16)00153-5","article-title":"Global epidemiology of avian influenza A H5N1 virus infection in humans, 1997\u20132015: a systematic review of individual case data","volume":"16","author":"Lai","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejps.2019.105124_bib0020","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1021\/acs.jmedchem.6b01852","article-title":"Expeditious lead optimization of isoxazole-containing influenza A virus M2-S31N inhibitors using the suzuki-miyaura cross-coupling reaction","volume":"60","author":"Li","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2019.105124_bib0021","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1021\/acs.jmedchem.5b01910","article-title":"Discovery of highly potent inhibitors targeting the predominant drug-resistant S31N mutant of the influenza A virus M2 proton channel","volume":"59","author":"Li","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2019.105124_bib0022","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1021\/acsinfecdis.6b00130","article-title":"Discovery of potent antivirals against amantadine-resistant influenza A viruses by targeting the M2-S31N proton channel","volume":"2","author":"Li","year":"2016","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejps.2019.105124_bib0023","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.2174\/0929867322666150227153919","article-title":"Inhibitors targeting the influenza virus hemagglutinin","volume":"22","author":"Li","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejps.2019.105124_bib0024","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1124\/mol.116.105346","article-title":"Pharmacological characterization of the spectrum of antiviral activity and genetic barrier to drug resistance of M2-S31N channel blockers","volume":"90","author":"Ma","year":"2016","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejps.2019.105124_bib0025","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.antiviral.2018.03.002","article-title":"Profiling the in vitro drug-resistance mechanism of influenza A viruses towards the AM2-S31N proton channel blockers","volume":"153","author":"Musharrafieh","year":"2018","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ejps.2019.105124_bib0026","doi-asserted-by":"crossref","first-page":"9345","DOI":"10.1073\/pnas.96.16.9345","article-title":"Generation of influenza A viruses entirely from cloned cDNAs","volume":"96","author":"Neumann","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejps.2019.105124_bib0027","doi-asserted-by":"crossref","first-page":"15219","DOI":"10.1021\/jacs.8b06741","article-title":"Inhibitors of the M2 proton channel engage and disrupt transmembrane networks of hydrogen-bonded waters","volume":"140","author":"Thomaston","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejps.2019.105124_bib0028","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(08)60493-6","article-title":"Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China","volume":"371","author":"Wang","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ejps.2019.105124_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2217\/fvl.15.95","article-title":"M2 as a target to combat influenza drug resistance: what does the evidence say?","volume":"11","author":"Wang","year":"2016","journal-title":"Future Virol."},{"key":"10.1016\/j.ejps.2019.105124_bib0030","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/bip.22623","article-title":"Recent progress in designing inhibitors that target the drug-resistant M2 proton channels from the influenza A viruses","volume":"104","author":"Wang","year":"2015","journal-title":"Biopolymers"},{"key":"10.1016\/j.ejps.2019.105124_bib0031","doi-asserted-by":"crossref","first-page":"12834","DOI":"10.1021\/ja204969m","article-title":"Molecular dynamics simulation directed rational design of inhibitors targeting drug-resistant mutants of influenza A virus M2","volume":"133","author":"Wang","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejps.2019.105124_bib0032","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1021\/jm301538e","article-title":"Discovery of novel dual inhibitors of the wild-type and the most prevalent drug-resistant mutant, S31N, of the M2 proton channel from influenza A virus","volume":"56","author":"Wang","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2019.105124_bib0033","doi-asserted-by":"crossref","first-page":"13844","DOI":"10.1021\/ja2050666","article-title":"Exploring organosilane amines as potent inhibitors and structural probes of influenza a virus M2 proton channel","volume":"133","author":"Wang","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejps.2019.105124_bib0034","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.sbi.2010.12.002","article-title":"Structural and dynamic mechanisms for the function and inhibition of the M2 proton channel from influenza A virus","volume":"21","author":"Wang","year":"2011","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.ejps.2019.105124_bib0035","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1073\/pnas.1216526110","article-title":"Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus","volume":"110","author":"Wang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejps.2019.105124_bib0036","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1021\/acs.jmedchem.7b01536","article-title":"In vitro pharmacokinetic optimizations of AM2-S31N channel blockers led to the discovery of slow-binding inhibitors with potent antiviral activity against drug-resistant influenza A viruses","volume":"61","author":"Wang","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2019.105124_bib0037","doi-asserted-by":"crossref","first-page":"9885","DOI":"10.1021\/ja4041412","article-title":"Drug-induced conformational and dynamical changes of the S31N mutant of the influenza M2 proton channel investigated by solid-state NMR","volume":"135","author":"Williams","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejps.2019.105124_bib0038","doi-asserted-by":"crossref","first-page":"17987","DOI":"10.1021\/ja508461m","article-title":"Flipping in the pore: discovery of dual inhibitors that bind in different orientations to the wild-type versus the amantadine-resistant S31N mutant of the influenza A virus M2 proton channel","volume":"136","author":"Wu","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejps.2019.105124_bib0039","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.2174\/0929867325666180706112940","article-title":"Focusing on the influenza virus polymerase: recent progress in drug discovery and assay development","volume":"26","author":"Zhang","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejps.2019.105124_bib0040","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1126\/science.1229455","article-title":"H5N1 hybrid viruses bearing 2009\/H1N1 virus genes transmit in guinea pigs by respiratory droplet","volume":"340","author":"Zhang","year":"2013","journal-title":"Science"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098719303975?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098719303975?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:49:09Z","timestamp":1760528949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098719303975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":40,"alternative-id":["S0928098719303975"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2019.105124","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of M2 channel blockers targeting the drug-resistant double mutants M2-S31N\/L26I and M2-S31N\/V27A from the influenza A viruses","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2019.105124","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105124"}}